reduce basal insulin dose when starting glp-1 receptor agonist Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Perioperative management of patients taking

and (iii) compound 2 and LY3502970 (a small molecule agonist), all in complex with heterotrimeric Gs

#Pharmacology #ClinicalPharmacology #DrugDiscovery #PharmaResearch #ObesityTreatment #HealthcareInnovation #DrugSafety

Their potential for disease modification and symptom relief, particularly in specific phenotypes, supports their further exploration as part of a personalized treatment approach.

I recently had the pleasure of speaking at the Colorado Academy of Nutrition and Dietetics Annual Conference on the topic of nutrition strategies for effective GLP-1 use in obesity treatment

Healthy fats: Olive oil, nuts, seeds, and fatty fish contain fats that delay gastric emptying, increasing GLP-1 activity

Discover how GLP-1 medications are reshaping the food and beverage industry, driving demand for smaller-portion, nutrient-dense products